Health Care & Life Sciences » Biotechnology | Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc.

Enanta Pharmaceuticals Inc.
Stock Exchange NASDAQ Stock Market
EPS
$3.72
Market Cap
$1.67 B
Shares Outstanding
19.67 M
Public Float
14.62 M

Profile

Address
500 Arsenal Street
Watertown Massachusetts 02472
United States
Employees -
Website http://www.enanta.com
Updated 07/08/2019
Enanta Pharmaceuticals, Inc. engages in the research and development of small molecule drugs for the treatment of viral infections and liver diseases. It offers the two protease inhibitors Maviret and the Viekira Pak for the treatment of chronic hepatitis C virus. The company was founded by Peter O.

Financials

View All

Jay R. Luly
President, Chief Executive Officer & Director
Kristine Peterson
Director